Chilton Investment Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.86M Sell
5,720
-243
-4% -$248K 0.16% 67
2026
Q1
$5.48M Sell
5,963
-4,088
-41% -$4.14M 0.13% 70
2025
Q4
$10.8M Sell
10,051
-2,438
-20% -$2.33M 0.23% 50
2025
Q3
$9.53M Buy
12,489
+9,332
+296% +$6.94M 0.19% 51
2025
Q2
$2.46M Buy
3,157
+19
+0.6% +$14.8K 0.05% 84
2025
Q1
$2.59M Buy
3,138
+259
+9% +$216K 0.06% 86
2024
Q4
$2.22M Buy
2,879
+42
+1% +$34.8K 0.06% 90
2024
Q3
$2.51M Sell
2,837
-335
-11% -$301K 0.07% 89
2024
Q2
$2.87M Sell
3,172
-18
-0.6% -$14.4K 0.08% 76
2024
Q1
$2.48M Buy
3,190
+133
+4% +$94.7K 0.07% 81
2023
Q4
$1.78M Sell
3,057
-48
-2% -$28K 0.05% 85
2023
Q3
$1.67M Buy
3,105
+1,058
+52% +$545K 0.05% 87
2023
Q2
$960K Sell
2,047
-420
-17% -$176K 0.03% 99
2023
Q1
$847K Buy
+2,467
New +$832K 0.03% 99
2016
Q1
– Sell
-14,800
Closed -$1.25M – 132
2015
Q4
$1.25M Hold
14,800
– – 0.04% 91
2015
Q3
$1.24M Hold
14,800
– – 0.04% 113
2015
Q2
$1.24M Buy
+14,800
New +$1.13M 0.05% 111

Other funds holding LLY

Chilton Investment Company's LLY Position: Q2 2026 in Review

Chilton Investment Company reduced its Eli Lilly (LLY) stake by 4.1% in Q2 2026, selling an estimated $248K and leaving 5,720 shares worth $6.86M. The position accounts for 0.16% of the portfolio, ranked #67.

Chilton Investment Company first reported a position in LLY in Q2 2015 and has held it in 17 quarters since. The position peaked at $10.8M in Q4 2025. 4,645 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Chilton Investment Company held 5,720 shares of Eli Lilly worth $6.86M as of Q2 2026.
  • Chilton Investment Company sold 243 Eli Lilly shares in Q2 2026, an estimated $248K.
  • Eli Lilly made up 0.16% of Chilton Investment Company's portfolio in Q2 2026, its #67 holding.
  • Chilton Investment Company first reported a position in Eli Lilly in Q2 2015 and has held it in 17 quarters since.
  • Chilton Investment Company's Eli Lilly position peaked at $10.8M in Q4 2025.
  • 4,645 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Chilton Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.